![](https://www.precisionvaccinations.com/sites/default/files/styles/article_metadata/public/blog-predicting_risks_and_benefits_lung_cancer_screening_lung_cancer_awareness_month-CDC_screening_poster-3408171838.png)
Global Phase 3 Study Launches for Second-Line Non-Small Cell Lung Cancer Vaccine
(Precision Vaccinations News)OSE Immunotherapeutics SA today announced the launch of its international Phase 3 clinical trial (Artemia) of Tedopi®, the ‘off-the-shelf’ neoepitope-based therapeutic cancer vaccine, in second-line treatment in patients with …